≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Patellar tendinitis

DOID EFO Endpoint Browser PheWeb

M13_PATELLARTEND

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M76.5
  • Hospital discharge: ICD-9 — 7266D
  • Cause of death: ICD-10 — M76.5
  • Cause of death: ICD-9 — 7266D

2 out of 7 registries used, show all original rules.

696

4. Check minimum number of events

None

696

5. Include endpoints

None

696

6. Filter based on genotype QC (FinnGen only)

696

Control definitions (FinnGen only)

Control exclude
M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M76
Name in latin
Tendinitis ligamenti patellae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6071 2095 3956
Only index persons 5910 2037 3873
Unadjusted period prevalence (%)
Whole population 0.09 0.06 0.11
Only index persons 0.12 0.07 0.15
Median age at first event (years)
Whole population 28.21 26.44 29.13
Only index persons 28.42 26.77 29.29

-FinnGen-

Key figures

All Female Male
Number of individuals 696 301 395
Unadjusted period prevalence (%) 0.14 0.10 0.17
Median age at first event (years) 34.93 32.82 36.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
608
Matched controls
6078
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.5
ICD-10 Finland
Patellar tendinitis
4062.9
323.0
562
18
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
29.6
57.7
78
30
M25.5
ICD-10 Finland
Pain in joint
4.5
56.6
254
828
7266D
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU APICITIS PATELLAE]
+∞
51.8
49
*
M01AH05
ATC
etoricoxib; oral
3.6
49.2
409
2189
NGL30
NOMESCO Finland
Plastic repair or reinsertation of tendon of patella
236.6
43.5
44
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
6.7
41.3
113
200
M54.4
ICD-10 Finland
Lumbago with sciatica
6.8
38.9
104
178
M22.4
ICD-10 Finland
Chondromalacia patellae
11.2
36.6
71
71
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
30.2
33.8
45
16
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
8.8
33.5
74
94
M54.5
ICD-10 Finland
Low back pain
3.3
32.9
206
814
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
8.4
32.9
75
100
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
15.6
32.1
53
37
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.8
30.9
295
1530
N02AX02
ATC
tramadol; systemic, rectal
3.0
30.8
231
1027
M01AB05
ATC
diclofenac; systemic, rectal
2.7
28.8
417
2720
NGL58
NOMESCO Finland
Tenolysis or tenosynovectomy of knee or lower leg
+∞
28.3
27
*
M01AC06
ATC
meloxicam; systemic, rectal
2.9
27.7
215
964
M79.6
ICD-10 Finland
Pain in limb
2.8
26.9
218
1002
N03AX16
ATC
pregabalin; oral
3.8
26.5
127
399
L15
ICPC
Knee symptom/complaint
3.4
26.2
150
541
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
4.3
23.9
94
246
M03BX02
ATC
tizanidine; oral
2.4
22.5
374
2458
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
65.0
22.0
25
*
M48.0
ICD-10 Finland
Spinal stenosis
83.2
21.8
24
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.4
21.6
67
136
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
20.7
232
1237
M01AE02
ATC
naproxen; oral, rectal
2.2
20.4
361
2394
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
5.1
19.7
64
137
M76.6
ICD-10 Finland
Achilles tendinitis
8.0
19.2
44
59
M17.1
ICD-10 Finland
Other primary gonarthrosis
3.5
18.5
94
305
H02AB06
ATC
prednisolone; systemic
2.2
18.4
252
1461
N03AX12
ATC
gabapentin; oral
4.1
18.2
74
198
M03BC01
ATC
orphenadrine (citrate); systemic
2.6
18.2
152
682
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
8.3
18.1
40
51
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
68.7
17.8
20
*
M23.8
ICD-10 Finland
Other internal derangements of knee
5.8
17.2
49
90
L03
ICPC
Low back symptom/complaint
2.7
16.9
129
548
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.1
16.3
40
60
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.5
16.2
143
657
NGL99
NOMESCO Finland
Other operation on muscle or tendon of knee or lower leg
164.0
15.5
16
*
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
13.7
14.8
25
19
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
7.6
14.7
34
47
N02BE01
ATC
paracetamol; systemic, rectal
2.1
14.7
474
3781
J01AA02
ATC
doxycycline; systemic
2.0
14.6
420
3190
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
14.4
137
651
M54.2
ICD-10 Finland
Cervicalgia
5.7
14.3
41
76
M01AE01
ATC
ibuprofen; systemic, rectal
2.7
13.7
554
4805
R03AC02
ATC
salbutamol; inhalant
1.9
13.6
298
2020
M02AA07
ATC
piroxicam; topical
2.2
13.5
169
914
M01AH01
ATC
celecoxib; oral (coxibs)
2.9
13.3
87
333
A02BC02
ATC
pantoprazole; systemic
1.9
13.2
315
2192
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
15.5
13.2
21
14
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
12.9
115
529
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
3.9
12.6
52
142
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
12.5
134
673
M02AA10
ATC
ketoprofen; topical
2.7
12.4
90
368
M43.1
ICD-10 Finland
Spondylolisthesis
21.8
12.1
17
8
M43.0
ICD-10 Finland
Spondylolysis
+∞
11.5
11
*
NGM99
NOMESCO Finland
Other operation on fascia, ganglion, or bursa of knee or lower leg
+∞
11.5
11
*
M54.3
ICD-10 Finland
Sciatica
8.6
11.4
24
29
ZXA00
NOMESCO Finland
Right side
2.3
11.3
118
582
R52.9
ICD-10 Finland
Pain, unspecified
3.4
11.3
54
167
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
11.2
184
1099
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
11.2
77
306
M01AX17
ATC
nimesulide; oral
2.4
11.0
96
435
M47.9
ICD-10 Finland
Spondylosis, unspecified
44.1
11.0
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
10.9
197
1219
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
61.1
10.7
12
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.1
10.6
60
209
9477
FHL
Cleansing or splitting of a tendon or tendon sheath (eg tenosynovectomy, tenolysis)
111.8
10.4
11
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
111.8
10.4
11
*
M47.82
ICD-10 Finland
Other spondylosis, cervical region
33.1
10.4
13
*
A02BC05
ATC
esomeprazole; systemic
1.9
10.3
190
1178
M54.6
ICD-10 Finland
Pain in thoracic spine
4.0
10.3
40
104
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
10.2
150
856
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
10.2
334
2499
M13.9
ICD-10 Finland
Arthritis, unspecified
3.8
10.0
42
117
M03BC51
ATC
orphenadrine, combinations; systemic
2.0
10.0
148
844
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
9.9
302
2200
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.4
9.8
35
84
M54.1
ICD-10 Finland
Radiculopathy
11.6
9.6
17
15
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
5.1
9.5
29
59
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.7
9.5
41
117
S89.9
ICD-10 Finland
Unspecified injury of lower leg
4.4
9.4
33
78
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
9.4
85
388
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
9.4
9
*
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
22.1
9.4
13
6
A02BC01
ATC
omeprazole; systemic
2.0
9.3
124
677
M01AX05
ATC
glucosamine; oral
2.8
9.0
60
232
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
18.9
9.0
13
7
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
18.9
9.0
13
7
N06AX21
ATC
duloxetine; oral
2.8
8.9
56
210
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.9
8.9
52
187
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
4.8
8.8
28
60
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
3.6
8.8
38
109
L86
ICPC
Back syndrome with radiating pain
5.4
8.7
25
48
S83.2
ICD-10 Finland
Tear of meniscus, current
2.8
8.6
54
202
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.2
8.6
45
150
R03DC03
ATC
montelukast; oral
2.2
8.5
87
423
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
8.5
431
3565
R52.2
ICD-10 Finland
Other chronic pain
7.5
8.5
19
26
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.9
8.4
133
774
J01FA06
ATC
roxithromycin; oral
1.7
8.4
202
1354
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
8.3
8
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.5
8.3
65
276
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
8.2
295
2210
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
8.2
80
381
L17
ICPC
Foot/toe symptom/complaint
2.0
8.1
117
657
R06.0
ICD-10 Finland
Dyspnoea
2.0
8.1
104
558
X58
ICD-10 Finland
Exposure to other specified factors
2.1
8.1
94
483
VALMI
NOMESCO Finland
NA
1.8
8.1
166
1057
M54
ICD-10 Finland
Dorsalgia
2.5
7.8
60
255
L08
ICPC
Shoulder symptom/complaint
2.1
7.8
86
434
R53
ICD-10 Finland
Malaise and fatigue
2.0
7.7
102
555
M50.3
ICD-10 Finland
Other cervical disc degeneration
45.5
7.7
9
*
R03BA05
ATC
fluticasone; inhalant
2.0
7.7
100
540
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
7.7
54
218
R01AD09
ATC
mometasone; nasal
1.6
7.7
261
1913
R51.80
ICD-10 Finland
Headache
2.1
7.6
87
443
M01AH02
ATC
rofecoxib; oral
2.7
7.5
48
184
A92
ICPC
Allergy/allergic reaction NOS
4.7
7.5
24
53
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
7.4
146
914
M24.2
ICD-10 Finland
Disorder of ligament
6.1
7.4
19
32
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.3
85
436
M04AA01
ATC
allopurinol; systemic
2.6
7.3
53
215
NG1BM
NOMESCO Finland
Knee and lower leg MRI examination with 3 Tesla magnet
+∞
7.3
7
*
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
+∞
7.3
7
*
J01DB01
ATC
cefalexin; oral
1.7
7.3
472
4074
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
7.3
89
469
J01DA01
ATC
[U] cefalexin; systemic
1.6
7.3
342
2714
R01AD12
ATC
fluticasone furoate; nasal
1.7
7.2
181
1214
L29
ICPC
Musculoskeletal sympt/complt other
2.9
7.1
41
146
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
7.1
156
1009
M77.1
ICD-10 Finland
Lateral epicondylitis
2.6
7.0
50
204
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.0
7.0
21
43
SPAT1263
SPAT
Sampling
1.6
7.0
227
1635
1220
FHL
Arthroscopy
3.6
7.0
30
87
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
7.0
107
615
H02AB04
ATC
methylprednisolone; systemic
2.2
7.0
68
326
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
3.8
7.0
28
77
-1
NOMESCO Finland
NA
1.6
6.9
216
1538
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.6
6.9
316
2478
ZXA05
NOMESCO Finland
Left side
1.9
6.9
104
592
M70.4
ICD-10 Finland
Prepatellar bursitis
4.6
6.8
22
49
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.4
6.8
19
36
S80.0
ICD-10 Finland
Contusion of knee
2.7
6.8
44
170
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
40.5
6.8
8
*
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
16.9
6.8
10
6
J01FA10
ATC
azithromycin; systemic
1.6
6.7
346
2781
N06AX11
ATC
mirtazapine; oral
1.7
6.7
154
1004
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
22.8
6.7
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
6.6
63
297
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.6
114
679
H02BX01
ATC
methylprednisolone, combinations; systemic
4.4
6.6
22
51
M10.9
ICD-10 Finland
Gout, unspecified
3.4
6.6
30
92
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.6
100
572
NGL20
NOMESCO Finland
Freeing of muscle of knee or lower leg
70.5
6.4
7
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
6.4
54
240
M94.2
ICD-10 Finland
Chondromalacia
14.5
6.4
10
7
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
5.6
6.3
17
31
M01AH03
ATC
valdecoxib; oral
3.3
6.3
30
95
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
6.3
6
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.4
6.2
50
217
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.8
6.2
37
136
S18
ICPC
Laceration/cut
1.6
6.2
186
1302
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
6.2
43
171
A02BC03
ATC
lansoprazole; oral
1.8
6.2
112
680
A02BA02
ATC
ranitidine; systemic
2.1
6.2
71
366
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.1
79
426
M01AB08
ATC
etodolac; oral
2.8
6.1
37
138
NG1DA
NOMESCO Finland
X-ray of knees
6.8
6.1
14
21
XKD00
NOMESCO Finland
Uroflowmetry
2.2
6.0
59
283
A01
ICPC
Pain general/multiple sites
3.0
6.0
34
119
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.1
6.0
30
99

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
498
3503
2.48
25.75
4.1
3.3
mm/h
8.2
9.1
1.17
468
3264
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
143
675
2.41
17.74
1.3
1.2
u/ml
8.8
8.7
0.01
61
288
(3037467) Urinalysis macro (dipstick) panel - Urine
445
3311
1.95
15.60
4.2
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
146
747
2.21
14.78
1.4
1.2
iu/ml
21.0
28.8
0.48
46
233
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
215
1330
1.89
12.65
2.5
2.6
u/l
55.4
57.7
0.18
210
1243
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
628
5458
2.54
12.57
13.2
10.2
mg/l
18.4
22.8
3.39
505
4122
(3031040) Bacteria [#/volume] in Urine by Automated count
395
2993
1.74
11.36
4.5
3.3
e6/l
867.7
118.6
—
9
36
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
486
3921
1.79
11.06
3.6
3.5
pmol/l
14.5
14.6
0.25
451
3616
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
27
6.43
10.31
2.1
1.6
%
55.4
61.8
0.20
11
22
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
16
8.26
9.76
1.8
1.2
%
39.2
29.5
—
6
11
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
449
3604
1.69
9.74
7.5
7.0
u/l
72.5
76.0
1.57
426
3392
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
538
4578
1.77
9.01
3.5
3.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
23
55
4.29
8.98
1.7
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
339
2567
1.63
8.94
6.3
6.7
e9/l
0.2
0.2
0.07
307
2281
(42870588) Differential panel, method unspecified - Blood
228
1562
1.68
8.93
5.5
6.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
312
2334
1.61
8.52
6.0
6.3
%
3.0
2.9
0.35
289
2205
(3019069) Monocytes/100 leukocytes in Blood
314
2353
1.61
8.51
6.4
6.6
%
8.4
8.5
0.25
296
2245
(3035350) Ketones [Presence] in Urine by Test strip
313
2346
1.61
8.46
3.5
2.7
estimate
0.0
0.0
0.00
61
447
(3021601) Nitrite [Presence] in Urine by Test strip
313
2348
1.61
8.42
4.6
3.8
estimate
0.0
0.0
0.00
63
470
(3023103) Potassium [Moles/volume] in Serum or Plasma
604
5360
1.96
8.37
12.7
11.2
mmol/l
3.9
3.9
0.03
597
5183
(3022096) Basophils/100 leukocytes in Blood
302
2249
1.61
8.36
5.8
6.6
%
0.8
0.7
2.01
282
2133
(3013650) Neutrophils [#/volume] in Blood by Automated count
364
2834
1.60
8.35
7.9
9.6
e9/l
3.9
4.0
0.18
327
2465
(3009261) Glucose [Presence] in Urine by Test strip
313
2353
1.60
8.32
3.6
2.7
estimate
0.1
0.0
0.78
60
440
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
306
2294
1.60
8.19
6.0
6.4
umol/l
10.2
11.6
2.74
291
2174
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
554
4804
1.75
8.08
4.2
4.0
mu/l
1.8
2.3
0.74
522
4480
(3019550) Sodium [Moles/volume] in Serum or Plasma
601
5340
1.92
8.08
12.6
11.1
mmol/l
139.8
139.6
0.67
595
5178
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
217
1501
1.65
8.04
3.5
2.9
ng/l
31.5
38.6
0.22
126
835
(3044889) 12 lead EKG panel
411
3315
1.59
7.94
2.9
3.0
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
265
1936
1.60
7.81
5.9
7.3
mmol/l
1.2
1.2
0.49
232
1675
(3026008) Bacteria identified in Urine by Culture
159
1020
1.72
7.80
2.5
2.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
77
3.47
7.59
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
177
1177
1.68
7.58
2.8
2.5
umol/l
2733.4
2800.7
0.01
158
1070
(3006315) Basophils [#/volume] in Blood
321
2471
1.56
7.44
6.4
6.2
e9/l
0.0
0.0
0.17
289
2167
(3018010) Neutrophils/100 leukocytes in Blood
316
2427
1.55
7.38
5.8
6.1
%
54.7
56.3
1.98
296
2312
(3032080) INR in Blood by Coagulation assay
218
1540
1.61
7.30
7.5
6.0
inr
1.1
1.2
0.66
72
494
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
646
5936
2.23
7.17
9.8
8.1
u/l
29.2
29.3
0.07
633
5755
(3013826) Glucose [Moles/volume] in Serum or Plasma
338
2648
1.54
7.14
4.3
4.8
mmol/l
6.5
6.6
0.33
318
2408
(3002030) Lymphocytes/100 leukocytes in Blood
319
2469
1.54
7.11
6.0
6.2
%
30.5
29.3
1.45
297
2343
(3001604) Monocytes [#/volume] in Blood
318
2463
1.54
7.05
6.5
6.2
e9/l
0.5
0.6
1.35
288
2158
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
252
1857
1.56
6.98
3.6
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
603
5437
1.82
6.71
3.9
3.6
mmol/l
4.7
4.7
0.06
580
5142
(3019198) Lymphocytes [#/volume] in Blood
328
2578
1.52
6.67
6.4
6.3
e9/l
1.9
2.0
0.82
291
2300
(3000850) Epithelial cells [#/volume] in Urine
130
824
1.71
6.58
3.4
2.4
e6/l
5.2
6.5
0.43
125
720
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
599
5416
1.76
6.26
3.8
3.5
mmol/l
1.4
1.4
0.02
571
5106
(3011397) Hemoglobin [Presence] in Urine by Test strip
146
968
1.64
6.21
3.5
2.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
293
2278
1.49
6.12
8.2
8.3
e9/l
0.0
0.0
0.26
258
1868
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
604
5482
1.77
6.12
4.2
3.8
mmol/l
2.9
2.9
0.12
575
5151
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
283
2187
1.50
6.08
4.0
3.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
63
326
2.03
6.05
2.3
2.3
au/ml
12.0
22.6
—
7
35
(40758558) Short blood count panel - Blood
169
1172
1.58
5.96
5.5
6.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
76
422
1.90
5.96
1.9
1.9
nmol/l
319.1
376.8
2.25
65
396
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
572
5130
1.65
5.90
10.4
9.1
ml/min/173m2
90.2
91.8
1.09
494
4123
(3010813) Leukocytes [#/volume] in Blood
682
6488
3.54
5.89
18.0
14.8
e9/l
6.4
6.6
2.05
673
6304
(40761511) CBC panel - Blood by Automated count
640
5930
1.99
5.82
11.6
9.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
566
5069
1.62
5.80
3.7
3.5
mmol/l
5.8
5.8
0.01
540
4711
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
155
1060
1.59
5.78
2.0
1.7
mg/l
1.2
1.0
0.32
109
772
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
169
2.39
5.78
1.4
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
681
6483
3.34
5.67
18.0
14.7
e12/l
4.7
4.7
0.01
673
6304
(3000475) Leukocytes [#/volume] in Synovial fluid
21
66
3.25
5.63
1.6
1.6
e6/l
9106.3
9392.7
0.02
14
47
(3007461) Platelets [#/volume] in Blood
679
6471
3.02
5.29
18.1
14.8
e9/l
250.9
252.5
0.29
672
6303
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
577
5229
1.61
5.21
3.6
3.3
mmol/l
1.3
1.3
0.14
555
4932
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
473
4128
1.46
4.97
3.4
2.9
u/l
45.3
44.2
0.08
454
3932
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
201
1502
1.48
4.90
3.8
2.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
163
2.27
4.87
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
145
1017
1.54
4.78
3.9
4.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
524
4682
1.48
4.73
4.8
4.5
mmol/mol
38.9
38.6
0.27
500
4427
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
225
1741
1.43
4.51
5.2
6.6
mmol/l
1.2
1.2
0.01
208
1611
(3018095) Leukocytes [#/volume] in Urine
202
1534
1.45
4.47
4.2
3.2
e6/l
76.3
100.2
0.17
156
1010
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
754
1.58
4.41
3.5
3.1
ng/l
30.0
704.2
3.05
69
498
(3044290) Cell count panel - Cerebral spinal fluid
25
101
2.53
4.34
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
92
596
1.63
4.24
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
55
308
1.85
4.24
4.6
5.3
%
0.0
0.2
1.03
14
87
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
229
1.98
4.21
1.6
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
170
1269
1.45
4.08
1.3
1.3
u/ml
1.4
2.1
0.50
47
347
(3002385) Erythrocyte distribution width [Ratio]
532
4815
1.45
4.08
12.9
12.6
%
13.3
13.4
1.20
527
4722
(3044640) Blood type and Crossmatch panel - Blood
188
1435
1.42
3.99
2.1
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
187
1429
1.42
3.94
2.9
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
67
409
1.71
3.88
10.9
14.1
inr
1.4
1.2
0.56
13
67
(3029937) Albumin [Presence] in Urine by Test strip
161
1200
1.44
3.88
4.4
2.8
estimate
0.0
0.0
0.17
61
454
(40768797) Stomach Pathology biopsy report
85
553
1.61
3.86
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
326
1.78
3.83
4.6
5.2
%
0.1
0.1
0.40
16
103
(3013512) EKG study
151
1116
1.45
3.80
3.2
3.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
39
202
1.99
3.80
4.4
2.8
e6/l
0.2
0.1
0.12
39
195
(3008898) HLA-B27 [Presence]
38
196
1.99
3.75
1.2
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
23
97
2.42
3.68
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
167
1265
1.42
3.67
3.9
2.8
e6/l
17.1
59.6
2.29
144
935
(3017181) Myelocytes/100 leukocytes in Blood
58
346
1.74
3.66
4.6
5.0
%
0.9
0.8
0.18
17
111
(3009542) Hematocrit [Volume Fraction] of Blood
596
5552
1.51
3.59
10.8
10.8
%
41.4
41.4
0.00
498
4621
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
95
647
1.54
3.55
2.8
2.5
e6/l
0.6
0.9
0.73
60
343
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
30
145
2.12
3.52
1.4
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
95
649
1.54
3.51
1.7
1.4
titre
331.4
429.0
0.39
14
138
(36304419) Bacteria [Presence] in Urine
152
1142
1.42
3.48
3.2
2.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
101
702
1.51
3.44
2.1
2.7
ug/g
131.2
123.4
0.07
76
564
(3019150) Specific gravity of Urine by Refractometry
136
1004
1.44
3.43
4.1
2.8
kg/l
1.0
1.0
0.31
18
121
(3004616) Nuclear Ab [Presence] in Serum
14
47
3.02
3.43
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
90
611
1.54
3.42
2.0
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
38
203
1.92
3.41
3.5
8.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
277
1.79
3.40
1.9
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
10
7.06
3.37
1.6
1.1
%
80.9
105.9
—
7
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
10
7.06
3.37
1.4
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
88
598
1.54
3.33
2.6
2.3
nmol/l
15.7
14.0
0.35
76
558
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
96
2.33
3.29
1.4
1.1
u/ml
2.3
3.9
0.82
12
38
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21
90
2.37
3.27
1.2
1.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
162
1245
1.39
3.25
5.5
4.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
33
3.37
3.20
1.2
1.5
nmol/l
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
180
1412
1.37
3.18
1.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
230
1875
1.34
3.16
1.7
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
98
2.29
3.16
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
61
2.66
3.15
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
112
810
1.46
3.14
2.5
2.4
mosm/kgh2o
594.1
582.7
0.13
103
698
(3020891) Body temperature
26
125
2.12
3.12
3.7
4.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
171
1337
1.37
3.08
3.3
3.1
mmol/l
2.3
2.4
0.30
158
1212
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
50
302
1.71
3.05
2.0
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
45
2.92
3.04
1.5
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
94
2.27
2.99
1.7
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
148
1136
1.38
2.98
3.9
4.1
ph
7.4
7.4
0.76
27
208
(3048929) Epstein Barr virus Ab [Presence] in Serum
48
289
1.71
2.97
1.4
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
149
1148
1.38
2.93
1.8
1.4
g/l
2.3
2.3
0.16
89
756
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
95
2.25
2.92
1.7
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
30
3.37
2.91
3.2
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
215
1754
1.33
2.91
5.0
5.3
g/l
37.5
36.8
0.97
200
1657
(3049717) Cytology report of Urine Cyto stain
25
122
2.09
2.90
1.6
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
52
323
1.66
2.87
2.7
2.3
ml/min/173m2
77.8
74.5
0.22
21
129
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
96
2.22
2.86
1.3
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
62
404
1.59
2.83
2.7
2.5
g/l
10.7
10.7
0.01
57
372
(3022621) pH of Urine by Test strip
41
240
1.75
2.80
2.7
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
147
1138
1.37
2.80
3.4
2.7
e6/l
0.2
0.4
1.61
123
823
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
97
2.20
2.79
1.0
1.1
u/ml
18.5
6.8
0.58
12
45
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
12
42
2.89
2.76
1.8
1.3
pmol/l
259.5
344.6
0.59
12
34
(3002179) Metamyelocytes/100 leukocytes in Blood
51
319
1.65
2.75
4.3
4.8
%
0.3
0.4
0.28
12
79
(3022948) Iron [Moles/volume] in Serum or Plasma
89
632
1.47
2.75
2.2
2.4
umol/l
14.1
14.5
0.20
81
592
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
132
2.01
2.73
1.1
1.1
u/ml
7.5
7.7
0.01
15
78
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
163
1287
1.35
2.73
3.6
3.1
%
19.9
21.2
0.43
51
459
(3006184) Hemoglobin [Mass/volume] in Capillary blood
18
79
2.31
2.69
2.1
2.6
g/l
138.3
131.8
0.39
12
61
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
92
2.21
2.69
1.5
1.1
u/ml
1.4
4.2
—
8
31
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
15
4.70
2.60
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
33
3.06
2.53
1.2
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
199
1636
1.30
2.50
3.8
3.4
ug/l
1.6
1.8
0.30
183
1496
(3028026) IgM [Mass/volume] in Serum or Plasma
50
322
1.60
2.43
2.4
1.7
g/l
1.2
1.4
0.71
45
297
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
34
2.97
2.42
2.4
2.6
pg
32.9
33.9
—
10
34
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
105
789
1.39
2.39
1.5
1.5
pmol/l
446.3
30980245.9
0.97
84
694
(3009508) Creatinine [Moles/volume] in Urine
172
1394
1.31
2.39
3.9
3.5
mmol/l
9.1
8.8
0.24
147
1213
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
132
1.93
2.39
1.0
1.1
u/ml
5.8
4.8
0.10
11
40
(3034426) Prothrombin time (PT)
7
17
4.15
2.36
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
105
2.03
2.33
1.7
1.4
ug/g
242.5
301.8
0.69
13
55
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
10
35
2.88
2.31
1.2
1.5
nmol/l
—
0.6
—
0
5
(4306422)
18
85
2.15
2.30
1.3
1.2
—
—
—
0
0
(4094501)
25
134
1.90
2.29
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
41
2.71
2.28
1.1
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
113
1.98
2.27
1.1
1.1
u/ml
3.4
3.1
0.05
13
45
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
18
3.92
2.25
1.0
1.2
%
108.3
109.3
—
7
18
(3004789) Transferrin [Mass/volume] in Serum or Plasma
82
597
1.42
2.24
2.0
2.3
g/l
2.4
2.4
0.13
75
559
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
137
1087
1.32
2.21
2.1
2.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
36
2.80
2.21
1.1
3.9
u/ml
447.1
682.7
—
10
36
(3025941) Bacteria identified in Stool by Culture
46
298
1.58
2.20
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
148
1188
1.31
2.20
4.0
4.3
mg/mmol
5.9
12.8
2.19
101
816
(4268621)
15
67
2.27
2.19
2.5
2.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
159
1.79
2.16
1.4
1.2
u/ml
258.1
239.3
0.10
17
95
(3012516) Albumin [Mass/volume] in Urine
140
1120
1.31
2.13
3.3
3.5
mg/l
1010.4
192.6
0.63
97
770
(3003396) Base excess in Arterial blood by calculation
58
400
1.49
2.11
5.2
11.1
mmol/l
0.6
1.0
0.47
44
323
(40761536) Microorganisms panel - Urine sediment
60
417
1.48
2.10
3.8
3.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
75
545
1.42
2.09
2.0
2.4
%
23.7
24.8
0.27
68
483
(4034850)
25
139
1.83
2.07
6.0
6.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
89
2.05
2.07
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
89
2.05
2.07
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
147
1.80
2.05
1.2
1.1
u/ml
0.5
2.3
0.97
12
65
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
405
1.47
1.99
1.6
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
21
3.36
1.97
1.0
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
127
1.84
1.96
1.1
1.1
u/ml
1.9
1.0
—
9
61
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
82
615
1.38
1.91
1.9
1.9
—
—
—
0
0
(1002224) Polysomnography panel
46
310
1.52
1.88
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
167
1.71
1.86
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
268
2352
1.23
1.85
2.8
2.7
ug/l
107.2
110.0
0.07
258
2210
(4010399)
44
295
1.52
1.85
1.4
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
66
2.14
1.83
2.8
2.6
%
18.0
17.0
—
9
36
(3000012) Reticulocyte production index
5
12
4.19
1.82
1.0
2.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
53
2.29
1.81
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
63
456
1.42
1.81
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
29
2.78
1.79
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
29
178
1.66
1.75
1.6
2.2
%
95.6
90.8
0.62
29
168
(3027273) Bicarbonate [Moles/volume] in Venous blood
26
155
1.70
1.75
4.5
3.7
mmol/l
24.2
25.1
0.78
26
148
(3002032) Base excess in Venous blood by calculation
49
341
1.47
1.74
3.8
4.1
mmol/l
1.6
1.7
0.05
39
271
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
13
3.87
1.72
3.0
4.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
183
1560
1.23
1.65
1.7
1.7
pmol/l
95.0
96.4
0.17
106
886
(3007853) Bacteria identified in Skin by Aerobe culture
70
527
1.36
1.62
2.1
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
277
2465
1.21
1.62
2.5
2.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
14
3.59
1.62
1.0
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
41
280
1.49
1.61
3.6
3.7
mmol/l
1.2
1.2
0.66
36
245
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
83
643
1.33
1.60
2.9
2.6
e6/l
1.7
2.1
0.42
49
340
(44813793)
8
32
2.52
1.60
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
147
1230
1.25
1.56
1.7
1.6
mmol/l
1.7
1.5
0.33
124
1076
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
122
1.74
1.56
1.7
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
47
334
1.44
1.52
2.2
2.4
u/l
7420.4
3596.9
0.31
17
141
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
107
867
1.28
1.49
2.6
3.3
ng/l
242.2
1153.1
8.87
85
698
(3023323) Follitropin [Units/volume] in Serum or Plasma
41
286
1.46
1.47
1.2
1.4
iu/l
22.4
20.8
0.11
31
245
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
28
2.51
1.45
3.1
2.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
41
287
1.46
1.44
2.8
3.2
e9/l
77.7
72.7
0.28
32
208
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
398
1.39
1.44
1.6
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
59
2.05
1.44
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
66
1.99
1.44
2.7
2.7
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
16
3.14
1.44
1.2
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
149
1.63
1.42
1.6
1.5
—
—
—
0
0
(4062490)
11
53
2.09
1.39
1.6
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
282
1.44
1.37
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
159
1.59
1.36
2.5
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
119
989
1.25
1.35
2.2
2.3
ug/l
0.6
0.7
1.07
53
514
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
241
1.48
1.35
1.6
2.8
ng/l
83.9
168.7
1.59
28
206
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
2.7
—
0.8
—
0
29
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
59
447
1.35
1.34
6.0
5.1
—
—
—
0
0
(4198724)
9
42
2.16
1.34
1.1
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
131
1102
1.23
1.33
2.4
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
168
1.57
1.33
3.0
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
276
1.44
1.32
4.2
2.8
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
41
0.00
1.31
0.0
2.2
—
133.7
—
0
35
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
80
637
1.29
1.29
2.8
2.8
mmol/l
2.4
2.4
0.39
71
563
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
202
1778
1.19
1.29
3.0
3.5
u/l
31.9
32.4
0.11
195
1695
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
70
548
1.31
1.28
2.3
2.8
umol/l
6.3
8.3
0.62
61
479
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
18
2.79
1.28
1.0
1.7
u/l
8.4
14.6
—
5
18
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
44
2.06
1.27
2.3
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
44
2.06
1.27
2.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
44
2.06
1.27
2.3
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
49
365
1.37
1.25
4.0
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
85
1.78
1.23
4.3
3.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
248
1.43
1.19
1.5
1.5
u/l
10.6
7.3
0.48
27
213
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
29
198
1.48
1.18
2.3
1.9
u/ml
18.1
43.5
1.33
29
193
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
38
2.12
1.18
1.6
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
100
829
1.24
1.17
1.4
1.4
nmol/l
19.6
19.6
0.00
87
724
(3024891) Influenza virus A+B Ag [Presence] in Specimen
28
191
1.49
1.15
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
20
2.51
1.15
3.0
3.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
20
2.51
1.15
1.0
1.0
u/ml
32.5
26.5
—
5
20
(3015235) Bicarbonate [Moles/volume] in Capillary blood
17
103
1.67
1.13
3.0
2.7
mmol/l
25.0
24.7
0.17
17
88
(3019225) pH of Specimen
49
372
1.34
1.13
3.6
4.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
30
209
1.46
1.12
2.9
3.5
g/l
134.5
132.8
0.15
30
202
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
22
144
1.55
1.10
1.5
1.4
u/ml
103.8
96.1
—
5
22
(3013290) Carbon dioxide [Partial pressure] in Blood
14
81
1.74
1.09
4.1
3.8
kpa
5.1
4.9
0.38
14
81
(3012501) Base excess in Blood by calculation
14
81
1.74
1.09
4.1
3.8
mmol/l
2.7
2.3
—
9
50
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
120
1.60
1.09
1.2
1.2
—
2.6
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
21
2.39
1.09
2.6
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
2.6
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
21
2.39
1.09
2.6
1.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
207
1851
1.17
1.09
2.1
2.2
nmol/l
72.8
72.1
0.13
198
1716
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
32
2.20
1.08
2.3
3.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
82
1.72
1.05
1.4
1.4
pmol/l
183.7
63.0
—
6
26
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
118
1009
1.20
1.04
2.0
2.0
mg/l
2.8
2.8
0.02
101
875
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
44
336
1.33
0.99
6.7
10.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
76
1.72
0.99
3.4
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
29
0.00
0.98
0.0
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
50
1.81
0.97
1.1
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
37
1.90
0.94
1.6
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
2.3
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
340
1.31
0.93
1.9
3.1
e9/l
3.4
4.1
2.00
34
295
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
218
1.39
0.93
1.8
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
64
520
1.25
0.92
1.8
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
52
1.74
0.92
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
18
118
1.54
0.91
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
192
1731
1.15
0.90
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
135
1.50
0.90
3.0
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
55
441
1.27
0.89
3.7
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
43
1.87
0.87
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
44
1.83
0.86
1.0
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
13
80
1.64
0.85
4.4
3.9
kpa
9.7
9.3
0.35
13
80
(3002256) Pathology report gross observation
69
572
1.23
0.85
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
59
481
1.25
0.84
3.5
2.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
65
1.70
0.82
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
101
872
1.19
0.82
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
59
483
1.24
0.82
3.5
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
97
836
1.19
0.81
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
61
502
1.24
0.81
1.3
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
48
1.67
0.79
1.3
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
58
477
1.24
0.78
3.5
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
183
1.38
0.77
2.0
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
211
1.34
0.73
1.2
1.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
109
0.55
0.72
6.7
5.6
umol/l
456.3
383.1
—
6
95
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
60
1.68
0.72
1.9
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
9
57
1.59
0.71
1.0
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
26
1.93
0.70
3.8
2.0
e9/l
0.1
0.1
—
5
26
(3035285) Chloride [Moles/volume] in Venous blood
7
41
1.71
0.70
1.9
1.8
mmol/l
107.6
105.5
—
7
41
(3041354) Potassium [Moles/volume] in Venous blood
7
41
1.71
0.70
1.9
1.8
mmol/l
4.2
4.0
—
7
41
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
41
1.71
0.70
1.9
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
58
1.56
0.70
2.8
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
57
475
1.22
0.69
3.6
2.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
61
1.65
0.68
1.9
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
61
1.65
0.68
1.9
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
61
1.65
0.68
1.9
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
61
1.65
0.68
1.9
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
61
1.65
0.68
1.9
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
339
1.25
0.68
1.5
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
142
1280
1.14
0.68
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
76
654
1.18
0.67
1.9
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
180
1.35
0.66
1.8
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
164
1.35
0.63
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
23
174
1.33
0.60
1.2
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
39
318
1.24
0.59
4.5
3.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
52
1.54
0.59
3.0
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
8
52
1.54
0.59
1.4
1.3
—
368.0
—
0
10
(4027681)
6
35
1.72
0.57
2.2
1.3
—
—
—
0
0
(4024509)
6
35
1.72
0.57
2.5
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
35
1.72
0.57
1.3
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
78
683
1.16
0.57
4.2
4.0
mmol/l
0.9
0.8
0.62
73
652
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
36
1.67
0.56
1.3
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
55
1.46
0.56
1.6
2.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
37
1.63
0.55
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
40
331
1.22
0.54
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
169
1.31
0.54
1.6
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
13
91
1.44
0.53
2.8
3.5
umol/l
30.8
37.2
—
8
82
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
134
1225
1.12
0.52
2.7
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
63
1.43
0.52
1.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
100
1.41
0.52
2.1
3.5
mg/l
40.9
24.5
—
8
64
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
408
1.19
0.51
2.6
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
177
1645
1.10
0.51
2.2
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
92
1.42
0.51
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
65
1.39
0.50
1.6
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
110
1.37
0.49
1.8
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
13
93
1.41
0.48
1.0
1.2
—
14.0
—
0
8
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
47
1.49
0.47
2.7
3.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
68
1.48
0.47
1.7
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
106
964
1.12
0.46
1.3
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
94
1.39
0.46
1.2
1.1
g/l
1.6
1.4
0.71
13
83
(3020191) Ethanol [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
2.0
1.4
promille
1.7
1.2
—
7
38
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
119
0.67
0.46
1.9
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
99
898
1.12
0.45
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
64
564
1.15
0.45
1.4
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
50
1.40
0.45
1.7
1.4
g/l
0.9
1.0
—
7
50
(3032773) Endomysium IgG Ab [Titer] in Serum
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
95
1.38
0.44
2.9
3.0
kpa
9.0
8.7
0.38
13
87
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
257
1.22
0.44
5.0
3.2
mmol/l
1.3
1.5
0.18
22
186
(4281824)
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
56
1.43
0.42
1.4
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
56
492
1.15
0.42
1.5
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
32
268
1.20
0.41
5.3
3.2
ph
7.4
7.4
—
7
29
(40768795) Lymph node Pathology biopsy report
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.4
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
186
1.24
0.41
1.5
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.2
—
8.8
—
0
17
(40768441) Liver Pathology biopsy report
5
34
1.47
0.40
2.2
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
97
1.35
0.39
1.5
2.4
umol/l
4.8
6.1
—
8
73
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
19
0.00
0.39
0.0
2.2
—
8.7
—
0
14
(3017569) Oxygen content in Arterial blood
0
19
0.00
0.39
0.0
5.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
80
1.38
0.38
2.6
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
109
1005
1.10
0.38
1.6
1.8
%
1.4
1.4
0.48
97
921
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
37
1.35
0.37
1.2
8.3
u/ml
—
63.1
—
0
16
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
72
652
1.12
0.36
1.7
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
77
0.65
0.36
8.4
2.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
77
0.65
0.36
1.2
1.1
u/l
9.7
31.5
—
5
68
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
153
1.25
0.35
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
20
243
0.82
0.34
1.5
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
82
1.35
0.34
1.3
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
118
1.28
0.33
2.1
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
23
192
1.20
0.32
2.8
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
53
1.32
0.31
1.3
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
544
1.11
0.30
4.0
3.5
%
29.7
30.4
0.23
53
388
(3000494) Fungus identified in Specimen by Culture
63
573
1.11
0.30
1.9
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
75
1.34
0.30
1.5
2.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
307
1.15
0.29
1.6
1.6
mu/l
258.7
291.3
0.24
29
278
(3034770) Mitochondria Ab [Titer] in Serum
21
176
1.20
0.29
1.6
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
62
1.29
0.28
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
102
956
1.08
0.27
2.0
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
61
559
1.10
0.26
1.9
1.6
nmol/l
1174.6
1103.0
0.29
48
441
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.3
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
141
1.21
0.26
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
114
1.23
0.25
2.9
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
179
1.18
0.25
1.3
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
327
0.88
0.23
2.6
5.2
ug/l
2.2
41.2
0.92
17
263
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
106
1.23
0.23
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
336
0.89
0.22
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
27
304
0.88
0.21
1.4
1.9
mg/l
2.0
3.6
1.07
13
208
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
10
0.00
0.21
0.0
4.7
—
490.9
—
0
10
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
44
402
1.10
0.21
1.3
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
9.6
—
0
12
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
103
0.77
0.21
1.4
2.1
g/l
0.4
0.8
—
8
97
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
251
0.87
0.21
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
43
1.16
0.21
1.8
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
48
1.25
0.20
1.3
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
48
1.25
0.20
3.0
3.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.0
—
11.6
—
0
8
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
59
1.19
0.18
2.1
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
176
1.14
0.17
1.1
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
66
0.76
0.17
1.2
2.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
29
263
1.11
0.16
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
29
263
1.11
0.16
1.5
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
68
1.18
0.16
2.3
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
16
183
0.87
0.16
1.4
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
85
810
1.06
0.16
1.8
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
29
264
1.10
0.16
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
31
284
1.10
0.15
1.5
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
80
1.13
0.15
2.2
4.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
140
1.15
0.15
1.3
1.1
—
—
—
0
0
(4035726)
38
352
1.08
0.15
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
29
265
1.10
0.15
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
88
0.79
0.14
1.6
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
141
1.14
0.14
1.3
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
21
189
1.11
0.14
7.7
3.8
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
100
0.80
0.13
2.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
267
1.09
0.13
1.2
1.4
miu/ml
185.6
250.4
0.44
12
130
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
210
0.90
0.12
1.6
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
114
1.14
0.12
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
54
1.11
0.09
2.2
2.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
18
165
1.09
0.09
7.8
4.1
mg/l
1.3
1.4
0.29
18
154
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.3
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.2
1.1
mg/l
300.6
277.4
—
5
54
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
65
0.77
0.08
1.4
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
88
1.14
0.08
1.7
3.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
156
1.09
0.08
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
74
0.81
0.07
1.0
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
148
1.08
0.06
1.1
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
119
1.09
0.06
1.2
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
119
1.09
0.06
1.2
1.8
g/l
6.6
7.0
—
8
97
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
119
1.09
0.06
1.2
1.8
g/l
3.4
3.9
—
7
92
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
100
1.10
0.05
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
110
1.09
0.05
1.2
1.9
g/l
2.9
3.0
—
7
94
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
191
0.94
0.04
1.6
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
201
0.94
0.04
6.4
3.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
91
1.10
0.04
1.4
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
57
557
1.03
0.04
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
200
0.95
0.04
7.1
15.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
23
220
1.05
0.03
1.5
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
392
1.02
0.01
1.3
1.2
iu/ml
109.7
150.1
0.35
19
167
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
17
177
0.96
0.01
6.9
3.4
mmol/l
24.2
24.8
0.52
17
169
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
216
0.97
0.00
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
96
1.04
0.00
2.8
2.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
156
1.03
0.00
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
117
1.03
0.00
1.3
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
214
0.98
0.00
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
108
1.02
0.00
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
13
131
0.99
0.00
3.3
3.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
169
1.01
0.00
2.6
3.7
g/l
0.2
0.3
—
8
82
(3004588) Protein electrophoresis panel - Serum or Plasma
20
201
0.99
0.00
1.4
2.0
—
—
—
0
0
(44806118)
6
60
1.00
0.00
1.7
1.9
—
—
—
0
0
(44790049)
6
60
1.00
0.00
1.7
1.9
—
—
—
0
0
(44790047)
6
60
1.00
0.00
1.7
1.9
—
—
—
0
0
(44790048)
6
60
1.00
0.00
1.7
1.9
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.5
—
3.9
—
0
8
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
51
0.98
0.00
1.8
1.6
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.0
—
1338.4
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
8.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
10.9
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
191.3
—
0
6
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
2.3
—
7.2
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
16.5
—
0
7
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
7.9
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
59.1
—
0
7
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
86
0.93
0.00
1.3
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
10.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
53
0.94
0.00
1.0
1.4
nmol/l
1.4
1.1
—
5
48
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
4.0
—
0
5
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
98
0.92
0.00
1.2
2.2
—
1520.0
—
0
6
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
3.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
53
0.94
0.00
1.4
2.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.9
—
0.7
—
0
8
(3035637) Corticotropin [Mass/volume] in Plasma
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.9
—
0
6
(3025130) Human papilloma virus identified in Specimen
8
86
0.93
0.00
1.1
1.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.5
—
20.2
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_PATELLARTEND and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
M13_PATELLARTEND 0.525 [0.4, 0.68] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 63 out of 2855 males with M13_PATELLARTEND died.

Mortality risk

Mortality risk for people of age

years, who have M13_PATELLARTEND.

N-year risk Females Males
1 No data 0.118%
5 No data 0.594%
10 No data 1.445%
15 No data 2.857%
20 No data 4.989%

Relationships between endpoints

↥

Index endpoint: M13_PATELLARTEND – Patellar tendinitis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data